In Vitro Inhibition of Influenza Virus Using CRISPR/Cas13a in Chicken Cells

Advances in the field of CRISPR/Cas systems are expanding our ability to modulate cellular genomes and transcriptomes precisely and efficiently. Here, we assessed the Cas13a-mediated targeted disruption of RNA in chicken fibroblast DF1 cells. First, we developed a Tol2 transposon vector carrying the...

Full description

Bibliographic Details
Main Authors: Arjun Challagulla, Karel A. Schat, Timothy J. Doran
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Methods and Protocols
Subjects:
Online Access:https://www.mdpi.com/2409-9279/4/2/40
_version_ 1797530946016116736
author Arjun Challagulla
Karel A. Schat
Timothy J. Doran
author_facet Arjun Challagulla
Karel A. Schat
Timothy J. Doran
author_sort Arjun Challagulla
collection DOAJ
description Advances in the field of CRISPR/Cas systems are expanding our ability to modulate cellular genomes and transcriptomes precisely and efficiently. Here, we assessed the Cas13a-mediated targeted disruption of RNA in chicken fibroblast DF1 cells. First, we developed a Tol2 transposon vector carrying the Cas13a-msGFP-NLS (pT-Cas13a) transgene, followed by a stable insertion of the Cas13a transgene into the genome of DF1 cells to generate stable DF1-Cas13a cells. To assess the Cas13a-mediated functional knockdown, DF1-Cas13a cells were transfected with the combination of a plasmid encoding DsRed coding sequence (pDsRed) and DsRed-specific crRNA (crRNA-DsRed) or non-specific crRNA (crRNA-NS). Fluorescence-activated cell sorting (FACS) and a microscopy analysis showed reduced levels of DsRed expression in cells transfected with crRNA-DsRed but not in crRNA-NS, confirming a sequence-specific Cas13a mediated mRNA knockdown. Next, we designed four crRNAs (crRNA-IAV) against the PB1, NP and M genes of influenza A virus (IAV) and cloned in tandem to express from a single vector. DF1-Cas13a cells were transfected with plasmids encoding the crRNA-IAV or crRNA-NS, followed by infection with WSN or PR8 IAV. DF1 cells transfected with crRNA-IAV showed reduced levels of viral titers compared to cells transfected with crRNA-NS. These results demonstrate the potential of Cas13a as an antiviral strategy against highly pathogenic strains of IAV in chickens.
first_indexed 2024-03-10T10:37:11Z
format Article
id doaj.art-790165d038ec4ba6ae0bbfe82dbc3a41
institution Directory Open Access Journal
issn 2409-9279
language English
last_indexed 2024-03-10T10:37:11Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series Methods and Protocols
spelling doaj.art-790165d038ec4ba6ae0bbfe82dbc3a412023-11-21T23:15:18ZengMDPI AGMethods and Protocols2409-92792021-06-01424010.3390/mps4020040In Vitro Inhibition of Influenza Virus Using CRISPR/Cas13a in Chicken CellsArjun Challagulla0Karel A. Schat1Timothy J. Doran2CSIRO Health and Biosecurity, Australian Centre for Disease Preparedness, Geelong 3220, AustraliaDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USACSIRO Health and Biosecurity, Australian Centre for Disease Preparedness, Geelong 3220, AustraliaAdvances in the field of CRISPR/Cas systems are expanding our ability to modulate cellular genomes and transcriptomes precisely and efficiently. Here, we assessed the Cas13a-mediated targeted disruption of RNA in chicken fibroblast DF1 cells. First, we developed a Tol2 transposon vector carrying the Cas13a-msGFP-NLS (pT-Cas13a) transgene, followed by a stable insertion of the Cas13a transgene into the genome of DF1 cells to generate stable DF1-Cas13a cells. To assess the Cas13a-mediated functional knockdown, DF1-Cas13a cells were transfected with the combination of a plasmid encoding DsRed coding sequence (pDsRed) and DsRed-specific crRNA (crRNA-DsRed) or non-specific crRNA (crRNA-NS). Fluorescence-activated cell sorting (FACS) and a microscopy analysis showed reduced levels of DsRed expression in cells transfected with crRNA-DsRed but not in crRNA-NS, confirming a sequence-specific Cas13a mediated mRNA knockdown. Next, we designed four crRNAs (crRNA-IAV) against the PB1, NP and M genes of influenza A virus (IAV) and cloned in tandem to express from a single vector. DF1-Cas13a cells were transfected with plasmids encoding the crRNA-IAV or crRNA-NS, followed by infection with WSN or PR8 IAV. DF1 cells transfected with crRNA-IAV showed reduced levels of viral titers compared to cells transfected with crRNA-NS. These results demonstrate the potential of Cas13a as an antiviral strategy against highly pathogenic strains of IAV in chickens.https://www.mdpi.com/2409-9279/4/2/40chickenCRISPR/Cas13acrRNAinfluenza A virus (IAV)
spellingShingle Arjun Challagulla
Karel A. Schat
Timothy J. Doran
In Vitro Inhibition of Influenza Virus Using CRISPR/Cas13a in Chicken Cells
Methods and Protocols
chicken
CRISPR/Cas13a
crRNA
influenza A virus (IAV)
title In Vitro Inhibition of Influenza Virus Using CRISPR/Cas13a in Chicken Cells
title_full In Vitro Inhibition of Influenza Virus Using CRISPR/Cas13a in Chicken Cells
title_fullStr In Vitro Inhibition of Influenza Virus Using CRISPR/Cas13a in Chicken Cells
title_full_unstemmed In Vitro Inhibition of Influenza Virus Using CRISPR/Cas13a in Chicken Cells
title_short In Vitro Inhibition of Influenza Virus Using CRISPR/Cas13a in Chicken Cells
title_sort in vitro inhibition of influenza virus using crispr cas13a in chicken cells
topic chicken
CRISPR/Cas13a
crRNA
influenza A virus (IAV)
url https://www.mdpi.com/2409-9279/4/2/40
work_keys_str_mv AT arjunchallagulla invitroinhibitionofinfluenzavirususingcrisprcas13ainchickencells
AT karelaschat invitroinhibitionofinfluenzavirususingcrisprcas13ainchickencells
AT timothyjdoran invitroinhibitionofinfluenzavirususingcrisprcas13ainchickencells